Cargando…
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
The global COVID-19 pandemic has affected the world’s population by causing changes in behavior, such as social distancing, masking, restricting people’s movement, and evaluating existing medication as potential therapies. Many pre-existing medications such as tocilizumab, ivermectin, colchicine, in...
Autores principales: | Shirazi, Farshad M., Mirzaei, Roya, Nakhaee, Samaneh, Nejatian, Amir, Ghafari, Shokouh, Mehrpour, Omid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817475/ https://www.ncbi.nlm.nih.gov/pubmed/35123559 http://dx.doi.org/10.1186/s40001-022-00645-8 |
Ejemplares similares
-
Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view
por: Shirazi, Farshad M., et al.
Publicado: (2020) -
A double-edged sword of using opioids and COVID-19: a toxicological view
por: Ataei, Mahshid, et al.
Publicado: (2020) -
Assessment of cloth masks ability to limit Covid-19 particles spread: a systematic review
por: Ataei, Mahshid, et al.
Publicado: (2021) -
Metal and bacterial contamination of illicit drugs
por: Schimmel, Jonathan, et al.
Publicado: (2018) -
Opium addiction as new source of lead poisoning: An emerging epidemic in Iran
por: Nakhaee, Samaneh, et al.
Publicado: (2018)